Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Total Liabilities: 2019-2024

Historic Total Liabilities for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $51.7 million.

  • Eton Pharmaceuticals' Total Liabilities rose 309.79% to $81.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.4 million, marking a year-over-year increase of 309.79%. This contributed to the annual value of $51.7 million for FY2024, which is 217.87% up from last year.
  • Per Eton Pharmaceuticals' latest filing, its Total Liabilities stood at $51.7 million for FY2024, which was up 217.87% from $16.3 million recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Total Liabilities ranged from a high of $51.7 million in FY2024 and a low of $9.8 million during FY2021.
  • Its 3-year average for Total Liabilities is $26.6 million, with a median of $16.3 million in 2023.
  • Per our database at Business Quant, Eton Pharmaceuticals' Total Liabilities declined by 7.70% in 2021 and then skyrocketed by 217.87% in 2024.
  • Eton Pharmaceuticals' Total Liabilities (Yearly) stood at $10.7 million in 2020, then decreased by 7.70% to $9.8 million in 2021, then climbed by 21.53% to $12.0 million in 2022, then spiked by 36.07% to $16.3 million in 2023, then spiked by 217.87% to $51.7 million in 2024.